Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|September 25, 2023
Discrimination, Reliability, Sensitivity, and Specificity of Robotic Surgical Proficiency Assessment With Global Evaluative Assessment of Robotic Skills and Binary Scoring Metrics: Results From a Randomized Controlled TrialRuben De Groote, Stefano Puliatti, Marco Amato, et al.
European Urology Oncology|January 21, 2026
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized TrialThomas Zilli, Shankar Siva, Sigmund Brabrand, et al.
The Lancet. Oncology|May 8, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
European Urology Focus|January 2, 2021
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer MetastasesThomas Zilli, Piet Dirix, Reino Heikkilä, et al.
Frontiers in Surgery|December 27, 2016
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node DissectionLisa Moris, Thomas Van den Broeck, Lorenzo Tosco, et al.
European Urology Oncology|October 11, 2023
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 TrialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
Cancer Cell|January 15, 2020
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic CandidatesJermaine Goveia, Katerina Rohlenova, Federico Taverna, et al.
Pageof 11